Drag a card by its title · ⚙ to size, swap or remove

The company

Pulse Biosciences, Inc

PLSE · Nasdaq

Health CareMedical DevicesLeading

PLSE stood above a rising 150-day average in 38 of the last 52 weekly readings, including each of the last 36 weeks. It is 41.6% above that average now. Medical Devices: 27% of its 181 stocks in an uptrend (−7 points in four weeks); Health Care: 26% (−10 points in four weeks).

SEC filings

Statistics

Rotation: Leading
Weeks in an uptrend: 36 in a row
Industry in uptrend: 27% -7 in 4 wk
Insider buys, 12 months: $53.6M
Insider sales, 12 months: $5.9M
Officials’ trades on record: 0
Institutions holding: 105 (+12)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 38 of 52 weeks.

20 Apr – 19 Oct

Medical Devices: A minority of its stocks are in an uptrend and the share has been slipping. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026

Open-market buys above the line and sales below, in dollars.

Congress and officials

No member of Congress or official has disclosed a trade in it.

Insiders

Buy orders, 12 months8

Sale orders, 12 months7

Buyers · sellers3 · 1

Who	Did	Shares	Traded
Liane Rae TeplitskyChief Operating Officer	bought	1,001at $49.95	1 Sep 2026filed 2 Sep 2026
Liane Rae TeplitskyChief Operating Officer	bought	1,024at $48.80	31 Aug 2026filed 2 Sep 2026
Liane Rae TeplitskyChief Operating Officer	bought	1,034at $48.35	28 Aug 2026filed 28 Aug 2026
Liane Rae TeplitskyChief Operating Officer	bought	1,036at $48.24	26 Aug 2026filed 28 Aug 2026
Robert W. DugganDirector, 10% owner	bought	660,233at $19.69	11 May 2026filed 11 May 2026
Paul A. LavioletteChief Executive Officer	bought	15,000at $19.69	11 May 2026filed 11 May 2026
Paul A. LavioletteChief Executive Officer	bought	15,000at $19.69	11 May 2026filed 11 May 2026
Robert W. DugganDirector, 10% owner	bought	660,233at $19.69	11 May 2026filed 15 May 2026
Kevin Patrick DanahyChief Commercial Officer	sold	5,000at $23.64	18 Feb 2026filed 23 Feb 2026
Kevin Patrick DanahyChief Commercial Officer	sold	20,000at $23.63	17 Feb 2026filed 17 Feb 2026
Kevin Patrick DanahyChief Commercial Officer	sold	20,000at $23.53	13 Feb 2026filed 17 Feb 2026
Kevin Patrick DanahyChief Commercial Officer	sold	20,000at $23.37	12 Feb 2026filed 17 Feb 2026

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders105+12 on the quarter

New · exited24 · 11

Reported value$279.6M

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

Manager	Shares	Change
BlackRock, Inc.added · filed 7 Aug 2026	1,466,702$40.7M	+126,924+9.5%
BANK OF AMERICA CORPadded · filed 14 Aug 2026	1,446,611$40.1M	+580,550+67.0%
VANGUARD CAPITAL MANAGEMENT LLCreduced · filed 13 Aug 2026	788,640$21.9M	-27,212−3.3%
Portolan Capital Management, LLCadded · filed 14 Aug 2026	753,333$20.9M	+19,961+2.7%
Balyasny Asset Management L.P.added · filed 14 Aug 2026	718,103$19.9M	+452,939+170.8%
CITADEL ADVISORS LLCadded · filed 14 Aug 2026	626,514$17.4M	+484,364+340.7%
GEODE CAPITAL MANAGEMENT, LLCadded · filed 12 Aug 2026	536,276$14.9M	+44,330+9.0%
STATE STREET CORPadded · filed 7 Aug 2026	529,624$14.7M	+72,697+15.9%
MASSACHUSETTS FINANCIAL SERVICES COreduced · filed 3 Aug 2026	462,734$12.8M	-1650.0%
UBS Group AGadded · filed 13 Aug 2026	275,669$7.6M	+241,715+711.9%